Immunization of Colorectal Cancer Patients with Modified Ovine Submaxillary Gland Mucin and Adjuvants Induces IgM and IgG Antibodies to Sialylated Tn

Cancer Research

Volumn 52, Issue 20, 1992, Pages 5663-5667

  O'Boyle, Kevin P ^a   Zamore, Rochelle ^a   Adluri, Sucharita ^a   Cohen, Alfred ^a   Kemeny, Nancy ^a   Welt, Sydney ^a   Lloyd, Kenneth O ^a   Oettgen, Herbert F ^a   Old, Lloyd J ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CARBOHYDRATE ANTIGEN; CYCLOPHOSPHAMIDE; EPITOPE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUCIN; PHOSPHORYL LIPID A;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM TUMOR; ERYTHEMA; HUMAN; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INTRADERMAL DRUG ADMINISTRATION; LYMPHADENOPATHY; PRIORITY JOURNAL; SIALYLATION; SUBMANDIBULAR GLAND;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; COLORECTAL NEOPLASMS; HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNE SERA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUCINS; SHEEP; SUBMANDIBULAR GLAND; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES;

EID: 0026673512     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cohen, A. M., Shank, B., and Friedman, M. A. Colorectal cancer. In: V. T. De Vita, Jr., S. Hellman, and Steven A. Rosenberg (eds.), Cancer, Principles and Practice of Oncology, Ed. 3, Vol. 1, pp. 895-964. Philadelphia: J. B. Lippincott Company, 1989.
2. Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. G., Glick, J. H., Veeder, M. H., and Mailliard, J. A. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med., 322: 352-358, 1990.
3. Laurie, J. A., Moertel, C. G., Fleming, T. R., Wieand, H. S., Leigh, J. E., Rubin, J., McCormack, G. W., Gerstner, J. B., Krook, J. E., Malliard, J., Twito, D. I., Morton, R. F., Tschetter, K., and Barlow, J. F. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J. Clin. Oncol., 7: 1447-1456,1989.
4. Hoover, H. C., Jr., Surdyke, M. G., Dangel, R. B., Peters, L. C., and Hanna, M. G. Prospectively randomized trial of adjuvant active specific immunotherapy for human colorectal cancer. Cancer (Phila.), 55: 1236-1243,1985.
5. Springer, G. F. T and Tn, general carcinoma autoantigens. Science (Washington DC), 224: 1198-1206, 1984.
6. Numata, Y., Nakada, H., Fukui, S., Kitagawa, H., Ozaki, K., Inoue, M., Kawasaki, T., Funakoshi, I., and Yamashina, I. A. Monoclonal antibody directed to Tn antigen. Biochem. Biophys. Res. Commun., 170: 981-985, 1990.
7. Blasco, E., Torrado, J., Belloso, L., Arocena, F., Gutierrez-Hoyos, A., and Cuadrado, E. T-antigen, a prognostic indicator of high recurrence index in transitional carcinoma of the bladder. Cancer (Phila.), 61: 1091-1095,1988.
8. Gold, D. V., and Mattes, M. J. Monoclonal B72.3 reacts with a core region structure of O-linked carbohydrates. Tumor Biol., 9: 137-144, 1988.
9. Thor, A., Ohuchi, N., Szpak, C. A., Johnston, W. W., and Schlom, J. The distribution of oncofetal antigen TAG-72 defined by monoclonal antibody B72.3. Cancer Res., 46: 3118-3124, 1986.
10. Ohoka, H., Shinomiya, H., Yokoyama, M., Ochi, K., Takeuchi, M., and Utsumi, S. Thomsen-Freidenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence. Urol. Res., 13: 47-50, 1985.
11. Ghazizadeh, M., Kagawa, S., Izumi, K., and Kurokawa, K. Immunohis-tochemical localization of T-antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate. J. Urol., 132: 1127-1130, 1984.
12. Springer, G. F. Tn epitope (jV-acetyl-D-galactosamine-O-serine/threonine) density in primary breast cancer: a functional predictor of aggressiveness. Mol. Immunol., 26: 1-5, 1989.
13. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori, S-I., and Kim, Y. S. Sialosyl Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (Phila.), 66: 1960-1966, 1990.
14. Ernst, C. S., Shen, J-W., Litwin, S., Herlyn, M., Koprowski, H., and Sears, H. F. Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma. J. Natl. Cancer Inst., 77: 387-395, 1986.
15. Kobayashi, H., Toshihiko, T., and Kawashima, Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J. Clin. Oncol., 10:95-101, 1992.
16. Bray, J., Maclean, G. D., Dusel, F. J., McPherson, T. A. Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer a correlation with disease burden. Clin. Exp. Immunol., 47: 176-182, 1982.
17. Itzkowitz, S. H., Yuan, M., Montgomerym, C. K., Kjeldsen, T., Takahashi, H. K., Bigbee, W. L., and Kim, Y. S. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res., 49: 197-204, 1989.
18. Umpleby, R., and Williamson, N. Peculiarities of mucinous colorectal carcinoma. Br. J. Surg., 72:715-718, 1985.
19. Halvorsen, T. B., and Seim, E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J. Clin. Pathol. (Lond.), 41: 1068-1072, 1988.
20. Symonds, D. A., and Vickery, A. L. Mucinous carcinoma of the colon and rectum. Cancer (Phila.), 37: 1891-1900, 1976.
21. Minsky, B. D., Mies, C., Rich, T. A., Recht, A., and ChafTey, J. T. Colloid carcinoma of the colon and rectum. Cancer (Phila.), 60: 3103-3112, 1987.
22. Fung, P. Y. S., Madej, M., Koganty, R. R., and Longenecker, B. M. Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res., 50: 4308-4314, 1990.
23. Singhal, A., Fohn, M., and Hakomori, S-I. Induction of a-N-acetylgalactosamine-D-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res., 51: 1406-1411, 1991.
24. Warren, L. The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 234: 1971-1975, 1959.
25. Lloyd, K., and Savage, A. High performance anion exchange chromatography of reduced oligosaccharides from sialomucins. Glycoconjugate J., 8: 493-498, 1991.
26. Livingston, P. O., Ritter, G., and Calves, M. J. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2, and GD3 in the mouse. Cancer Immunol. Immunother., 29: 179-184, 1989.
27. Hawkes, R., Niday, E., and Gordon, J. A. Dot-immunobinding assay for monoclonal and other antibodies. Anal. Biochem., 119: 142-147, 1982.
28. Livingston, P. O., Cunningham-Rundles, S., Marfleet, G., Gneco, C., Wong, G. Y., Schiffman, G., Enker, W. E., and Hoffman, M. K. Inhibition of suppressor cell activity by cyclophosphamide in patients with malignant melanoma. J. Biol. Response Modif., 6: 392-403, 1987.